| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 10.738 | 13.798 | 11.443 | 975 | 11.456 | 37.831 |
| Total Income - EUR | - | - | - | 0 | 10.738 | 13.798 | 11.443 | 975 | 11.456 | 37.863 |
| Total Expenses - EUR | - | - | - | 155 | 16.624 | 12.335 | 10.357 | 3.407 | 17.861 | 40.139 |
| Gross Profit/Loss - EUR | - | - | - | -155 | -5.886 | 1.463 | 1.086 | -2.432 | -6.404 | -2.276 |
| Net Profit/Loss - EUR | - | - | - | -155 | -5.993 | 1.121 | 693 | -2.499 | -6.404 | -2.276 |
| Employees | - | - | - | 0 | 1 | 0 | 0 | 1 | 0 | 1 |
Check the financial reports for the company - Biosof Naturis S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 2.740 | 2.910 | 2.639 | 3.254 | -420 | 8.395 | 2.177 |
| Inventories | - | - | - | 2.594 | 866 | 574 | 590 | 134 | 4.770 | 1.952 |
| Receivables | - | - | - | 0 | 1.890 | 1.350 | 664 | -632 | -288 | 220 |
| Cash | - | - | - | 145 | 154 | 716 | 2.000 | 78 | 3.913 | 5 |
| Shareholders Funds | - | - | - | -91 | -6.082 | -4.846 | -4.046 | -6.558 | -12.942 | -15.146 |
| Social Capital | - | - | - | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | - | - | - | 2.831 | 8.992 | 7.485 | 7.300 | 6.138 | 21.337 | 17.323 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Biosof Naturis S.r.l.